Iron overload is being recognized to play a carcinogenic role in hepatocellular carcinoma and other cancers ... to gauge iron overload such as MRI T2* and evaluation for cirrhosis by techniques ...

MASH patients with clinically significant liver fibrosis (stages F2 and F3) are at high risk for progression to cirrhosis, which places them at greater risk for hepatocellular carcinoma ...

The diagnostic tools in this field principally involve US, contrast-enhanced CT scan, and magnetic resonance imaging (MRI ... For solid lesions, HCC, fibrolamellar carcinoma, choriocarcinoma ...

Subsequently, magnetic resonance imaging (MRI) of the upper abdomen was performed ... indicated that the mass was probably or definitely malignant and not HCC-specific (LR-M category). Liver biopsy ...

Liver biomarkers at baseline in addition to changes during follow-up are associated with cirrhosis and HCC in HDV.

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic biopsy technology, today announced ...

Research suggests that the HSD17B13 rs72613567 variant may mitigate the harmful effects of PNPLA3 mutations in liver fibrosis and even reduce the risk of hepatocellular carcinoma (HCC ...

Asian American, Native Hawaiian, and Pacific Islander (AANHPI) patients with early-stage hepatocellular carcinoma (HCC) have significantly better survival outcomes compared with non-Hispanic White ...